1. Home
  2. Labeler Index
  3. Blistex Inc.
  4. 10157-2127
  5. NDC Package Code: 10157-2127-1 Kanka Triple Action

NDC Package 10157-2127-1 Kanka Triple Action

Benzocaine And Menthol,Unspecified Form Gel Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
10157-2127-1
Package Description:
1 TUBE in 1 CARTON / 11.9 g in 1 TUBE
Product Code:
10157-2127
Proprietary Name:
Kanka Triple Action
Non-Proprietary Name:
Benzocaine And Menthol, Unspecified Form
Substance Name:
Benzocaine; Menthol, Unspecified Form
Usage Information:
Adults and children 2 years of age and olderApply to affected area up to 4 times daily or as directed by a dentist or doctorChildren between 2 and 12 years of ageAsk a doctor before use. Should be supervised in the use of this productChildren under 2 years of ageDo not use
11-Digit NDC Billing Format:
10157212701
NDC to RxNorm Crosswalk:
Product Type:
Human Otc Drug
Labeler Name:
Blistex Inc.
Dosage Form:
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
M022
Marketing Category:
OTC MONOGRAPH DRUG -
Start Marketing Date:
01-06-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 10157-2127-1?

The NDC Packaged Code 10157-2127-1 is assigned to a package of 1 tube in 1 carton / 11.9 g in 1 tube of Kanka Triple Action, a human over the counter drug labeled by Blistex Inc.. The product's dosage form is gel and is administered via oral form.

Is NDC 10157-2127 included in the NDC Directory?

Yes, Kanka Triple Action with product code 10157-2127 is active and included in the NDC Directory. The product was first marketed by Blistex Inc. on January 06, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 10157-2127-1?

The 11-digit format is 10157212701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-110157-2127-15-4-210157-2127-01